Cutler Group LP Intra Cellular Therapies, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Cutler Group LP holds 600 shares of ITCI stock, worth $51,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares

600

Previous 300 100.0%

Holding current value

$51,954

Previous $21,000 90.48%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$46.37 - $73.65 $13,911 - $22,095	300 New	300 $21,000
Q4 2022 Feb 07, 2023	BUY	$44.07 - $54.45 $7,932 - $9,801	180 New	180 $9,000
Q1 2022 Apr 14, 2022	SELL	$38.74 - $62.09 $340,912 - $546,392	-8,800 Reduced 83.13%	1,786 $109,000
Q4 2021 Jan 18, 2022	BUY	$35.2 - $53.42 $334,857 - $508,184	9,513 Added 886.58%	10,586 $554,000
Q3 2021 Oct 26, 2021	BUY	$28.72 - $42.49 $13,584 - $20,097	473 Added 78.83%	1,073 $40,000
Q2 2021 Jul 19, 2021	SELL	$29.3 - $44.5 $31,644 - $48,060	-1,080 Reduced 64.29%	600 $24,000
Q1 2021 Apr 26, 2021	SELL	$30.8 - $39.51 $12,320 - $15,804	-400 Reduced 19.23%	1,680 $57,000
Q4 2020 Jan 21, 2021	SELL	$23.34 - $32.22 $72,820 - $100,526	-3,120 Reduced 60.0%	2,080 $66,000
Q3 2020 Oct 27, 2020	BUY	$17.61 - $31.86 $42,264 - $76,464	2,400 Added 85.71%	5,200 $133,000
Q2 2020 Jul 22, 2020	BUY	$14.35 - $26.64 $14,350 - $26,640	1,000 Added 55.56%	2,800 $71,000
Q1 2020 May 07, 2020	BUY	$12.31 - $33.12 $16,003 - $43,056	1,300 Added 260.0%	1,800 $27,000
Q4 2019 Feb 06, 2020	BUY	$7.26 - $38.49 $2,178 - $11,547	300 Added 150.0%	500 $17,000
Q3 2019 Oct 28, 2019	SELL	$7.47 - $14.03 $25,398 - $47,702	-3,400 Reduced 94.44%	200 $1,000
Q1 2019 May 10, 2019	SELL	$10.9 - $14.09 $63,220 - $81,722	-5,800 Reduced 61.7%	3,600 $43,000
Q4 2018 Feb 05, 2019	BUY	$10.36 - $20.96 $21,756 - $44,016	2,100 Added 28.77%	9,400 $107,000
Q3 2018 Nov 07, 2018	SELL	$17.77 - $22.9 $61,288 - $78,982	-3,449 Reduced 32.09%	7,300 $158,000
Q2 2018 Aug 10, 2018	SELL	$17.33 - $23.4 $40,725 - $54,990	-2,350 Reduced 17.94%	10,749 $189,000
Q1 2018 May 11, 2018	BUY	$15.16 - $25.49 $64,248 - $108,026	4,238 Added 47.83%	13,099 $275,000
Q4 2017 Jan 17, 2018	SELL	$14.27 - $16.79 $395,264 - $465,066	-27,699 Reduced 75.76%	8,861 $128,000
Q3 2017 Oct 17, 2017	BUY	$10.77 - $22.1 $393,751 - $807,976	36,560	36,560 $576,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.17B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account